APO RESEARCH · REPORT
Estriol
Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.
Product & engineering
Understand the product.
Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.
Selected research
Industry Growth & Trends
Global Estriol Industry Growth and Trends Forecast to 2032
Market perspective
Estriol is a metabolite of estradiol and estrone. Its value is very low during non-pregnancy and is mainly synthesized by the liver. It is mainly synthesized by the fetal placenta. After synthesis, it is metabolized in the liver through maternal blood circulation and sulfuric acid or glucuronic acid Combined to form a combined E3, which is excreted from the urine. E3 plays an important role in the regulation of fetal intrauterine development and can affect the sensitivity of the pregnant uterus to oxytocin.
The leading producers in the sector are Jiangxi Yuneng Pharmaceutical, Shanghai Lianlu Industry and Jiangsu Yuanda SYM Pharmaceutical, with revenues of 28.20 percent, 13.44 percent and 21.48 percent respectively in 2019.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Estriol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Estriol market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Estriol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Estriol.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Estriol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Estriol Market by Company
Jiangxi Yuneng Pharmaceutical
Shanghai Lianlu Industry
Jiangsu Yuanda SYM Pharmaceutical
Estriol Segment by Type
Purity: <99%
Purity: ≥99%
Estriol Segment by Application
Pharmaceutical
Biological Research
Estriol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Estriol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Estriol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Estriol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Estriol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Estriol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity: <99%
- Purity: ≥99%
Applications
- Pharmaceutical
- Biological Research
Companies covered
- Jiangxi Yuneng Pharmaceutical
- Shanghai Lianlu Industry
- Jiangsu Yuanda SYM Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Estriol Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Estriol Sales Estimates and Forecasts (2021-2032)
- 1.3 Estriol Market by Type
- 1.3.1 Purity: <99%
- 1.3.2 Purity: ≥99%
- 1.4 Global Estriol Market Size by Type
- 1.4.1 Global Estriol Market Size Overview by Type (2021-2032)
- 1.4.2 Global Estriol Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Estriol Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Estriol Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Estriol Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Estriol Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Estriol Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Estriol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Estriol Industry Trends
- 2.2 Estriol Industry Drivers
- 2.3 Estriol Industry Opportunities and Challenges
- 2.4 Estriol Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Estriol Revenue (2021-2026)
- 3.2 Global Top Players by Estriol Sales (2021-2026)
- 3.3 Global Top Players by Estriol Price (2021-2026)
- 3.4 Global Estriol Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Estriol Major Company Production Sites & Headquarters
- 3.6 Global Estriol Company, Product Type & Application
- 3.7 Global Estriol Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Estriol Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Estriol Players Market Share by Revenue in 2025
- 3.8.3 2025 Estriol Tier 1, Tier 2, and Tier 3
4 Estriol Regional Status and Outlook
- 4.1 Global Estriol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Estriol Historic Market Size by Region
- 4.2.1 Global Estriol Sales in Volume by Region (2021-2026)
- 4.2.2 Global Estriol Sales in Value by Region (2021-2026)
- 4.2.3 Global Estriol Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Estriol Forecasted Market Size by Region
- 4.3.1 Global Estriol Sales in Volume by Region (2027-2032)
- 4.3.2 Global Estriol Sales in Value by Region (2027-2032)
- 4.3.3 Global Estriol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Estriol by Application
- 5.1 Estriol Market by Application
- 5.1.1 Pharmaceutical
- 5.1.2 Biological Research
- 5.2 Global Estriol Market Size by Application
- 5.2.1 Global Estriol Market Size Overview by Application (2021-2032)
- 5.2.2 Global Estriol Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Estriol Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Estriol Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Estriol Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Estriol Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Estriol Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Estriol Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Jiangxi Yuneng Pharmaceutical
- 6.1.1 Jiangxi Yuneng Pharmaceutical Company Information
- 6.1.2 Jiangxi Yuneng Pharmaceutical Business Overview
- 6.1.3 Jiangxi Yuneng Pharmaceutical Estriol Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Jiangxi Yuneng Pharmaceutical Estriol Product Portfolio
- 6.1.5 Jiangxi Yuneng Pharmaceutical Recent Developments
- 6.2 Shanghai Lianlu Industry
- 6.2.1 Shanghai Lianlu Industry Company Information
- 6.2.2 Shanghai Lianlu Industry Business Overview
- 6.2.3 Shanghai Lianlu Industry Estriol Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shanghai Lianlu Industry Estriol Product Portfolio
- 6.2.5 Shanghai Lianlu Industry Recent Developments
- 6.3 Jiangsu Yuanda SYM Pharmaceutical
- 6.3.1 Jiangsu Yuanda SYM Pharmaceutical Company Information
- 6.3.2 Jiangsu Yuanda SYM Pharmaceutical Business Overview
- 6.3.3 Jiangsu Yuanda SYM Pharmaceutical Estriol Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Jiangsu Yuanda SYM Pharmaceutical Estriol Product Portfolio
- 6.3.5 Jiangsu Yuanda SYM Pharmaceutical Recent Developments
7 North America by Country
- 7.1 North America Estriol Sales by Country
- 7.1.1 North America Estriol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Estriol Sales by Country (2021-2026)
- 7.1.3 North America Estriol Sales Forecast by Country (2027-2032)
- 7.2 North America Estriol Market Size by Country
- 7.2.1 North America Estriol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Estriol Market Size by Country (2021-2026)
- 7.2.3 North America Estriol Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Estriol Sales by Country
- 8.1.1 Europe Estriol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Estriol Sales by Country (2021-2026)
- 8.1.3 Europe Estriol Sales Forecast by Country (2027-2032)
- 8.2 Europe Estriol Market Size by Country
- 8.2.1 Europe Estriol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Estriol Market Size by Country (2021-2026)
- 8.2.3 Europe Estriol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Estriol Sales by Country
- 9.1.1 Asia-Pacific Estriol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Estriol Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Estriol Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Estriol Market Size by Country
- 9.2.1 Asia-Pacific Estriol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Estriol Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Estriol Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Estriol Sales by Country
- 10.1.1 South America Estriol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Estriol Sales by Country (2021-2026)
- 10.1.3 South America Estriol Sales Forecast by Country (2027-2032)
- 10.2 South America Estriol Market Size by Country
- 10.2.1 South America Estriol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Estriol Market Size by Country (2021-2026)
- 10.2.3 South America Estriol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Estriol Sales by Country
- 11.1.1 Middle East and Africa Estriol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Estriol Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Estriol Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Estriol Market Size by Country
- 11.2.1 Middle East and Africa Estriol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Estriol Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Estriol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Estriol Value Chain Analysis
- 12.1.1 Estriol Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Estriol Production Mode & Process
- 12.2 Estriol Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Estriol Distributors
- 12.2.3 Estriol Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst